Millennium Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,441,516
Closed -$350M 5902
2025
Q4
$350M Buy
3,441,516
+1,224,082
+55% +$98.3M 0.15% 95
2025
Q3
$121M Buy
2,217,434
+15,791
+0.7% +$789K 0.05% 344
2025
Q2
$117M Buy
2,201,643
+727,457
+49% +$37M 0.06% 325
2025
Q1
$63.8M Sell
1,474,186
-886,022
-38% -$44.9M 0.03% 591
2024
Q4
$133M Buy
2,360,208
+1,121,423
+91% +$69.8M 0.06% 288
2024
Q3
$84.4M Buy
1,238,785
+563,929
+84% +$31.8M 0.04% 520
2024
Q2
$28.5M Sell
674,856
-2,271,667
-77% -$125M 0.01% 1196
2024
Q1
$203M Buy
2,946,523
+2,721,096
+1,207% +$172M 0.09% 196
2023
Q4
$16.7M Sell
225,427
-78,229
-26% -$5.13M 0.01% 1687
2023
Q3
$20.7M Buy
303,656
+31,715
+12% +$2.69M 0.01% 1415
2023
Q2
$25.5M Sell
271,941
-252,478
-48% -$19.7M 0.01% 1190
2023
Q1
$35.6M Buy
524,419
+466,563
+806% +$30M 0.02% 913
2022
Q4
$2.86M Sell
57,856
-142,661
-71% -$5.83M ﹤0.01% 3254
2022
Q3
$6.51M Buy
+200,517
New +$8.27M ﹤0.01% 2642
2022
Q2
Sell
-4,026
Closed -$281K 7112
2022
Q1
$281K Sell
4,026
-112,066
-97% -$8.19M ﹤0.01% 5601
2021
Q4
$9.04M Buy
116,092
+107,397
+1,235% +$9.48M ﹤0.01% 2245
2021
Q3
$830K Sell
8,695
-41,946
-83% -$4.43M ﹤0.01% 4877
2021
Q2
$6.29M Sell
50,641
-235,640
-82% -$28.1M ﹤0.01% 2451
2021
Q1
$37.7M Sell
286,281
-172,666
-38% -$23.6M 0.03% 652
2020
Q4
$60.8M Sell
458,947
-445,488
-49% -$53.9M 0.04% 365
2020
Q3
$92.2K Buy
904,435
+270,070
+43% +$23.3M 0.11% 141
2020
Q2
$55.2M Buy
634,365
+546,028
+618% +$43.6M 0.08% 253
2020
Q1
$5.12M Sell
88,337
-75,304
-46% -$6.11M 0.01% 1324
2019
Q4
$15.1M Sell
163,641
-118,438
-42% -$10.4M 0.02% 1033
2019
Q3
$25.5M Buy
282,079
+272,562
+2,864% +$31.1M 0.04% 630
2019
Q2
$1.12M Sell
9,517
-419,731
-98% -$42.3M ﹤0.01% 2732
2019
Q1
$37.2M Sell
429,248
-65,861
-13% -$5.61M 0.06% 465
2018
Q4
$31.2M Sell
495,109
-30,024
-6% -$2.06M 0.05% 516
2018
Q3
$41.4M Sell
525,133
-413,963
-44% -$27M 0.05% 488
2018
Q2
$56.1M Buy
+939,096
New +$50.5M 0.07% 356
2017
Q4
Sell
-38,425
Closed -$1.81M 3869
2017
Q3
$1.81M Buy
38,425
+8,643
+29% +$348K ﹤0.01% 2225
2017
Q2
$1.05M Sell
29,782
-3,116,164
-99% -$96.2M ﹤0.01% 2425
2017
Q1
$74.3M Buy
3,145,946
+2,243,908
+249% +$44.5M 0.14% 199
2016
Q4
$12.1M Sell
902,038
-70,911
-7% -$1.14M 0.03% 818
2016
Q3
$18.1M Sell
972,949
-3,333,596
-77% -$58.7M 0.03% 625
2016
Q2
$52.8M Buy
4,306,545
+2,399,267
+126% +$18.1M 0.12% 194
2016
Q1
$12.9M Sell
1,907,278
-1,727,680
-48% -$11.1M 0.03% 693
2015
Q4
$33.6M Buy
3,634,958
+3,616,858
+19,983% +$33.6M 0.07% 380
2015
Q3
$326K Sell
18,100
-223,975
-93% -$5.14M ﹤0.01% 2873
2015
Q2
$7.2M Buy
+242,075
New +$6.08M 0.01% 1171
2015
Q1
Sell
-129,638
Closed -$3.56M 3730
2014
Q4
$3.56M Buy
129,638
+50,086
+63% +$1.22M 0.01% 1606
2014
Q3
$1.54M Buy
79,552
+9,524
+14% +$175K ﹤0.01% 2041
2014
Q2
$1.19M Buy
+70,028
New +$964K ﹤0.01% 2098
2013
Q3
Sell
-232,902
Closed -$3.24M 3372
2013
Q2
$3.24M Buy
+232,902
New +$2.53M 0.01% 1289

Other funds holding EXAS

Millennium Management's EXAS Position: Q1 2026 in Review

Millennium Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,441,516 shares — an estimated $350M sold.

Millennium Management first reported a position in EXAS in Q2 2013 and held it in 44 quarters. The position peaked at $350M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Millennium Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 3,441,516 Exact Sciences shares in Q1 2026, an estimated $350M.
  • Millennium Management first reported a position in Exact Sciences in Q2 2013 and held it in 44 quarters.
  • Millennium Management's Exact Sciences position peaked at $350M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.